These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 646547)

  • 41. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
    Leier CV; Desch CE; Magorien RD; Triffon DW; Unverferth DV; Boudoulas H; Lewis RP
    Am J Cardiol; 1980 Dec; 46(6):1039-44. PubMed ID: 7446418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
    Stein L; Henry DP; Weinberger MH
    Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prazosin and congestive heart failure: short- and long-term therapy.
    Rouleau JL; Warnica JW; Burgess JH
    Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precipitation of heart failure following sudden withdrawal of hydralazine.
    Black JR; Mehta J
    Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasodilator drugs.
    Gould L; Gopalaswamy C
    Compr Ther; 1984 Feb; 10(2):38-45. PubMed ID: 6423342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hemodynamic effects of prazosin in heart failure].
    Bassand JP; Becque O; Vial Y; Berthout P; Maurat JP
    Nouv Presse Med; 1979 Nov; 8(44):3663. PubMed ID: 534219
    [No Abstract]   [Full Text] [Related]  

  • 50. Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.
    Chatterjee K; Rouleau JL
    Acta Med Scand Suppl; 1981; 651():295-303. PubMed ID: 7034478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasodilator therapy for congestive heart failure.
    Dillon TR; Janos GG; Meyer RA; Benzing G; Kaplan S
    J Pediatr; 1980 Apr; 96(4):623-9. PubMed ID: 7359264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Progress in the therapy of acute and chronic cardiac insufficiency by means of systemic vasodilators. Studies with prazosin and nitroglycerin].
    Klein W; Brandt D; Harpf H; Goebel R
    Wien Med Wochenschr; 1979 Nov; 129(21):625-30. PubMed ID: 120080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
    Reyns PR; Romney D; Desser KB; Benchimol A
    Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydralazine in chronic CHF.
    Chatterjee K; Rouleau JL; Massie BM
    Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L; Foster PR; Friedman AW; Statza J; McHenry PL
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.
    Colucci WS; Williams GH; Braunwald E
    Ann Intern Med; 1980 Sep; 93(3):452-3. PubMed ID: 7436166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of refractory congestive heart failure with prazosin.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):626-34. PubMed ID: 6267922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prazosin in chronic congestive heart failure due to ischemic heart disease.
    Antani JA; Antani NJ; Nanivadekar AS
    Clin Cardiol; 1991 Jun; 14(6):495-500. PubMed ID: 1810687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure.
    Colucci WS; Williams GH; Braunwald E
    Am Heart J; 1981 Sep; 102(3 Pt 2):615-21. PubMed ID: 6115578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.